Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Antibodies to recombinant human alpha-L-iduronidase prevent disease correction in cortical bone in MPS I mice

Molecular Therapy — Methods & Clinical Development(2025)10.1016/j.omtm.2024.101405Source: DataRank Database

Antibodies to recombinant human alpha-L-iduronidase prevent disease correction in cortical bone in MPS I mice is a research paper published in Molecular Therapy — Methods & Clinical Development (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.00)OA: goldTopics (30)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Steven Q. Le,Shih‐hsin Kan ORCID,Quang D. Bui ORCID,Michael D. Brodt,Patricia Dickson ORCID

Live enrichment

PubMed:40123743 PMC:PMC11928967 OpenAlex:https://openalex.org/W4405998913

National Institutes of Health

Grant: 1F31HL165903-01A1

Pulmonary endothelium targeted adenoviral gene therapy for the correction of mucopolysaccharidosis type I

National Institutes of Health

Grant: 1P30AR074992-01

Resource Based Center for Musculoskeletal Biology and Medicine (Overall Application)

National Science Foundation

Grant: 1745038

Graduate Research Fellowship Program (GRFP)

FWCI

0.00

Citation Percentile

0.0%

goldLicense: CC BY NC ND

journalhttps://doi.org/10.1016/j.omtm.2024.101405

publisherhttps://doi.org/10.1016/j.omtm.2024.101405

publisherhttps://api.elsevier.com/content/article/PII:S2329050124002213?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2329050124002213?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40123743

Fields of Study

Lysosomal Storage Disorders ResearchResearch on Leishmaniasis StudiesGlycogen Storage Diseases and MyoclonusMedicineBiology03 medical and health sciences0302 clinical medicine

Keywords

Mucopolysaccharidosis IRecombinant DNAMucopolysaccharidosis type IMucopolysaccharidosisAlpha (finance)MedicineAntibodyDiseaseImmunologyBiologyEnzyme replacement therapyPathologyGeneticsSurgeryGeneImmune responseHurlerScheieHurler-scheieQH573-671Original ArticleQH426-470Cytology

Sustainable Development Goals

SDG 0: Good health and well-being

Antibodies to recombinant human alpha-L-iduronidase prevent disease correction in cortical bone in MPS I mice

FAIR Checklist

Authors (6)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)